SJ

Shashibala Jha

Active Director Director DIN 09527843
DIN 09527843 First appointment Mar 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value •••• Premium profile

About Shashibala Jha

Data last updated:

Shashibala Jha is a Director at Adiros Pharma Private Limited (since 2022). The company operates in Healthcare. Adiros Pharma Private Limited reported revenue of ₹63.2 Lakh (FY 2025).

DIN 09527843
Primary Designation Director
Industry Healthcare
First Appointment 07 Mar 2022
Oldest Company Age 5 yrs
Largest company Adiros Pharma Private Limited · ₹63.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Adiros Pharma Private Limited U85100DL2021PTC385644
Director07 Mar 20222021₹63.2 Lakh (FY 2025)Active

Board colleagues of Shashibala Jha

NameDINCompanyDesignation
Anita Jha09295183Adiros Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Adiros Pharma Private Limited
Premium access

Shareholding and investment profile for Shashibala Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shashibala Jha

Shashibala Jha currently holds 1 directorship: Adiros Pharma Private Limited (Director, since 07 Mar 2022, revenue ₹63.2 Lakh (FY 2025)).

Shashibala Jha was first appointed on 07 Mar 2022 as Director at Adiros Pharma Private Limited.

The current boards of Shashibala Jha's companies include Anita Jha (Adiros Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available